Functional Vitamin E deficiency in ApoE4 patients with Alzheimer's disease - PubMed (original) (raw)
doi: 10.1159/000090868. Epub 2006 Jan 11.
Affiliations
- PMID: 16407653
- DOI: 10.1159/000090868
Functional Vitamin E deficiency in ApoE4 patients with Alzheimer's disease
Emilie Mas et al. Dement Geriatr Cogn Disord. 2006.
Abstract
Oxidative stress has been implicated in the development of Alzheimer's disease (AD). Consequently, antioxidant therapies including Vitamin E (VitE) supplementation for both prevention and treatment of neurodegenerative diseases currently appears to be a promising avenue of research. The aim of the present study was to examine the relationship between AD and the ApoE phenotype, lipid parameters and VitE levels in a large cohort of elderly subjects. No absolute deficit was observed in plasma VitE levels. However in AD, ApoE4 is not associated with an increase in total cholesterol (TC) and VitE levels. Moreover, our results suggest that oxidative stress-induced injury and protection by VitE in AD are related to the ApoE phenotype. Our study strongly supports the hypothesis of an impairment of lipophilic antioxidant delivery to neuronal cells in AD leading to a tissular antioxidant deficiency which could facilitate oxidative stress.
Similar articles
- Association of apolipoprotein E polymorphism with age-related macular degeneration and Alzheimer's disease in south-western Hungary.
Kovács KA, Pámer Z, Kovács A, Fekete S, Miseta A, Kovács B, Kovács GL. Kovács KA, et al. Ideggyogy Sz. 2007 Mar 30;60(3-4):169-72. Ideggyogy Sz. 2007. PMID: 17451062 - Effect of apoE genotype and vitamin E on biomarkers of oxidative stress in cultured neuronal cells and the brain of targeted replacement mice.
Huebbe P, Jofre-Monseny L, Boesch-Saadatmandi Ch, Minihane AM, Rimbach G. Huebbe P, et al. J Physiol Pharmacol. 2007 Dec;58(4):683-98. J Physiol Pharmacol. 2007. PMID: 18195481 - Plasma levels of antioxidants are not associated with Alzheimer's disease or cognitive decline.
Engelhart MJ, Ruitenberg A, Meijer J, Kiliaan A, van Swieten JC, Hofman A, Witteman JC, Breteler MM. Engelhart MJ, et al. Dement Geriatr Cogn Disord. 2005;19(2-3):134-9. doi: 10.1159/000082884. Epub 2004 Dec 23. Dement Geriatr Cogn Disord. 2005. PMID: 15627760 - Vitamin E in neurodegenerative disorders: Alzheimer's disease.
Kontush K, Schekatolina S. Kontush K, et al. Ann N Y Acad Sci. 2004 Dec;1031:249-62. doi: 10.1196/annals.1331.025. Ann N Y Acad Sci. 2004. PMID: 15753151 Review. - Inflammation, cytokines, immune response, apolipoprotein E, cholesterol, and oxidative stress in Alzheimer disease: therapeutic implications.
Candore G, Bulati M, Caruso C, Castiglia L, Colonna-Romano G, Di Bona D, Duro G, Lio D, Matranga D, Pellicanò M, Rizzo C, Scapagnini G, Vasto S. Candore G, et al. Rejuvenation Res. 2010 Apr-Jun;13(2-3):301-13. doi: 10.1089/rej.2009.0993. Rejuvenation Res. 2010. PMID: 20462385 Review.
Cited by
- Diminished circulating retinol and elevated α-TOH/retinol ratio predict an increased risk of cognitive decline in aging Chinese adults, especially in subjects with ApoE2 or ApoE4 genotype.
Huang X, Zhang H, Zhen J, Dong S, Guo Y, Van Halm-Lutterodt N, Yuan L. Huang X, et al. Aging (Albany NY). 2018 Dec 20;10(12):4066-4083. doi: 10.18632/aging.101694. Aging (Albany NY). 2018. PMID: 30573705 Free PMC article. - Dietary omega 3 polyunsaturated fatty acids and Alzheimer's disease: interaction with apolipoprotein E genotype.
Barberger-Gateau P, Samieri C, Féart C, Plourde M. Barberger-Gateau P, et al. Curr Alzheimer Res. 2011 Aug;8(5):479-91. doi: 10.2174/156720511796391926. Curr Alzheimer Res. 2011. PMID: 21605054 Free PMC article. Review. - Vitamin E and Alzheimer's disease: what do we know so far?
Browne D, McGuinness B, Woodside JV, McKay GJ. Browne D, et al. Clin Interv Aging. 2019 Jul 18;14:1303-1317. doi: 10.2147/CIA.S186760. eCollection 2019. Clin Interv Aging. 2019. PMID: 31409980 Free PMC article. Review. - Oxidative Stress Induced Mitochondrial Failure and Vascular Hypoperfusion as a Key Initiator for the Development of Alzheimer Disease.
Aliev G, Palacios HH, Gasimov E, Obrenovich ME, Morales L, Leszek J, Bragin V, Solís Herrera A, Gokhman D. Aliev G, et al. Pharmaceuticals (Basel). 2010 Jan 19;3(1):158-187. doi: 10.3390/ph3010158. Pharmaceuticals (Basel). 2010. PMID: 27713247 Free PMC article. Review. - Increased amyloid-β peptide-induced memory deficits in phospholipid transfer protein (PLTP) gene knockout mice.
Desrumaux C, Pisoni A, Meunier J, Deckert V, Athias A, Perrier V, Villard V, Lagrost L, Verdier JM, Maurice T. Desrumaux C, et al. Neuropsychopharmacology. 2013 Apr;38(5):817-25. doi: 10.1038/npp.2012.247. Epub 2012 Dec 3. Neuropsychopharmacology. 2013. PMID: 23303044 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous